HIV
Scripps Research and IAVI report positive findings from HIV vaccine Phase I trial
February 4, 2021HIV
Scripps Research and IAVI have returned positive Phase I results in their hunt for a HIV vaccine, detecting a targeted …
ViiV’s long-acting HIV drug Cabenuva gets FDA approval
January 22, 2021Medical Communications HIV, ViiV Healthcare
The FDA has approved ViiV’s Cabenuva, the first and only complete long-acting regimen for the treatment of HIV-1 infection in …
ViiV and Chelsea & Westminster Hospital launch digital service for HIV patients
January 18, 2021Sales and Marketing HIV, ViiV Healthcare
Global specialist HIV company ViiV Healthcare and Chelsea and Westminster Hospital NHS Foundation Trust have launched a new service, Klick, …
ViiV gets EU approval for children’s HIV treatment
January 13, 2021Research and Development EU, HIV, ViiV
ViiV Healthcare, the global specialist HIV company, has received marketing authorisation from the European Commission for Tivicay (dolutegravir) 5mg dispersible …
ViiV Healthcare announces authorisation of Europe’s first long-acting HIV injection
December 21, 2020Sales and Marketing GlaxoSmithKline, HIV, ViiV
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline, has announced the authorisation of Europe’s first complete long-acting …
Gilead’s lenacapavir meets primary goal in heavily treated and multidrug resistant HIV-1
November 19, 2020Research and Development Gilead, HIV, pharma
Gilead has pulled back the curtain on promising new data for its long-acting HIV-1 capsid inhibitor lenacapavir for heavily treated …
Viiv Healthcare’s cabotegravir effective in HIV prevention in women
November 9, 2020Sales and Marketing AIDS, HIV
Viiv Healthcare’s cabotegravir is more effective in preventing HIV in women than the oral standard of care, according to an …
Gilead’s Biktarvy proves non-inferior to standard care for HIV in Black and African American patients
October 22, 2020Research and Development Biktarvy, Gilead, HIV, pharma
Gilead has revealed promising new Phase 3 data reinforcing the non-inferiority of Biktarvy (bictegravir 50mg/emtricitabine 200mg/tenofovir alafenamide 25mg) compared to …
ViiV Healthcare secures FDA approval for Rukobia combo in multidrug-resistant HIV-1
July 6, 2020Sales and Marketing FDA, HIV, ViiV Healthcare
ViiV Healthcare, the HIV specialist majority owned by GSK which also counts Shionogi and Pfizer among its shareholders, has secured …
Florida approve plan to release 750 million genetically modified mosquitoes to stop the spread of disease
June 19, 2020Medical Communications AIDS, HIV, mosquitoes
Florida state regulators have gained approval to release 750 million genetically modified mosquitoes across the state to reduce the spread …
ViiV Healthcare scores world-first approval in Canada for monthly HIV regimen Cabenuva
March 23, 2020Sales and Marketing Cabenuva, Canada, HIV, pharma
ViiV Healthcare has secured its first global approval for its once-monthly treatment Cabenuva, it has emerged, to replace current antiretroviral …
Top Ten most popular articles on Pharmafile.com this week
March 13, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Coronavirus Wuhan, HIV, HIV/AIDS, UK Coronavirus, coronavirus
HIV treatment featured heavily in the news this week, as Uganda is preparing to enter the final stages of developing …
A man from London becomes second person to be cured of HIV
March 11, 2020Research and Development HIV, HIV AIDS, HIV Drug, HIV cure, HIV/AIDS, anti-HIV
Adam Castillejo is the second man to be cured of HIV, after being free of the virus for more than …
Anti-HIV drug PrEP has 30% lower concentration levels in pregnant African adolescents and young women
March 10, 2020Manufacturing and Production AIDS, HIV, PrEP, PrEP HIV, insulin
Pregnant African adolescents and young women who took the HIV drug PrEP were found to have 30% lower levels of …
Uganda finalising clinical trials on new injectable HIV drug
March 9, 2020Sales and Marketing AIDS, HIV, Uganda HIV, Uganda HIV/AIDS, uganda
Uganda is preparing to enter the final stages of developing a new HIV treatment to reduce stigma and discrimination of …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
